Literature DB >> 28978468

Host MicroRNAs-221 and -222 Inhibit HIV-1 Entry in Macrophages by Targeting the CD4 Viral Receptor.

Robert Lodge1, Jérémy A Ferreira Barbosa1, Félix Lombard-Vadnais1, Julian C Gilmore1, Alexandre Deshiere2, Annie Gosselin3, Tomas Raul Wiche Salinas3, Mariana G Bego1, Christopher Power4, Jean-Pierre Routy5, Petronela Ancuta6, Michel J Tremblay7, Éric A Cohen8.   

Abstract

Macrophages are heterogeneous immune cells with distinct origins, phenotypes, functions, and tissue localization. Their susceptibility to HIV-1 is subject to variations from permissiveness to resistance, owing in part to regulatory microRNAs. Here, we used RNA sequencing (RNA-seq) to examine the expression of >400 microRNAs in productively infected and bystander cells of HIV-1-exposed macrophage cultures. Two microRNAs upregulated in bystander macrophages, miR-221 and miR-222, were identified as negative regulators of CD4 expression and CD4-mediated HIV-1 entry. Both microRNAs were enhanced by tumor necrosis factor alpha (TNF-α), an inhibitor of CD4 expression. MiR-221/miR-222 inhibitors recovered HIV-1 entry in TNF-α-treated macrophages by enhancing CD4 expression and increased HIV-1 replication and spread in macrophages by countering TNF-α-enhanced miR-221/miR-222 expression in bystander cells. In line with these findings, HIV-1-resistant intestinal myeloid cells express higher levels of miR-221 than peripheral blood monocytes. Thus, miR-221/miR-222 act as effectors of the antiviral host response activated during macrophage infection that restrict HIV-1 entry.
Copyright © 2017 The Author(s). Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  CD4; HIV-1; RNA-seq; TNF-α; antiviral; macrophage; macrophage activation; miR-221; miR-222; microRNA

Mesh:

Substances:

Year:  2017        PMID: 28978468     DOI: 10.1016/j.celrep.2017.09.030

Source DB:  PubMed          Journal:  Cell Rep            Impact factor:   9.423


  27 in total

1.  HIV-associated sensory polyneuropathy and neuronal injury are associated with miRNA-455-3p induction.

Authors:  Eugene L Asahchop; William G Branton; Anand Krishnan; Patricia A Chen; Dong Yang; Linglong Kong; Douglas W Zochodne; Bruce J Brew; M John Gill; Christopher Power
Journal:  JCI Insight       Date:  2018-12-06

Review 2.  Novel strategies to target proprotein convertase subtilisin kexin 9: beyond monoclonal antibodies.

Authors:  Nabil G Seidah; Annik Prat; Angela Pirillo; Alberico Luigi Catapano; Giuseppe Danilo Norata
Journal:  Cardiovasc Res       Date:  2019-03-01       Impact factor: 10.787

Review 3.  The Effect of miRNA Gene Regulation on HIV Disease.

Authors:  Romona Chinniah; Theolan Adimulam; Louansha Nandlal; Thilona Arumugam; Veron Ramsuran
Journal:  Front Genet       Date:  2022-05-04       Impact factor: 4.772

Review 4.  Immune Cell-Derived Extracellular Vesicles in the Face of Pathogenic Infections.

Authors:  Somayeh Keshtkar; Saeede Soleimanian; Maryam Kaviani; Fatemeh Sabet Sarvestani; Negar Azarpira; Zahra Asvar; Sara Pakbaz
Journal:  Front Immunol       Date:  2022-06-30       Impact factor: 8.786

5.  MiRNA-103 downmodulates CCR5 expression reducing human immunodeficiency virus type-1 entry and impacting latency establishment in CD4+ T cells.

Authors:  Nicolas Bellini; Robert Lodge; Tram N Q Pham; Jaspreet Jain; Thomas T Murooka; Alon Herschhorn; Nicole F Bernard; Jean-Pierre Routy; Cécile L Tremblay; Éric A Cohen
Journal:  iScience       Date:  2022-09-28

6.  Hepatitis C Virus Cure in Human Immunodeficiency Virus Coinfection Dampens Inflammation and Improves Cognition Through Multiple Mechanisms.

Authors:  Bing Sun; Linda Abadjian; Alexander Monto; Heather Freasier; Lynn Pulliam
Journal:  J Infect Dis       Date:  2020-07-06       Impact factor: 5.226

7.  Isolation, Transfection, and Culture of Primary Human Monocytes.

Authors:  Karlie Plaisance-Bonstaff; Celeste Faia; Dorota Wyczechowska; Duane Jeansonne; Cecilia Vittori; Francesca Peruzzi
Journal:  J Vis Exp       Date:  2019-12-16       Impact factor: 1.355

8.  MicroRNAs and exosomes: key players in HIV pathogenesis.

Authors:  J Sadri Nahand; F Bokharaei-Salim; M Karimzadeh; M Moghoofei; S Karampoor; H R Mirzaei; A Tabibzadeh; A Jafari; A Ghaderi; Z Asemi; H Mirzaei; M R Hamblin
Journal:  HIV Med       Date:  2019-11-22       Impact factor: 3.180

9.  Human Immunodeficiency Virus Type 1 Vpr Mediates Degradation of APC1, a Scaffolding Component of the Anaphase-Promoting Complex/Cyclosome.

Authors:  Jérémy A Ferreira Barbosa; Samantha Sparapani; Jonathan Boulais; Robert Lodge; Éric A Cohen
Journal:  J Virol       Date:  2021-07-12       Impact factor: 5.103

10.  Identifying potential human and medicinal plant microRNAs against SARS-CoV-2 3'UTR region: A computational genomics assessment.

Authors:  Naman Mangukia; Priyashi Rao; Kamlesh Patel; Himanshu Pandya; Rakesh M Rawal
Journal:  Comput Biol Med       Date:  2021-07-19       Impact factor: 4.589

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.